Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer,
myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).
Company Details
- Employees
- 346
- Address
- 85 Wells Avenue, Newton,ma 02459,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.karyopharm.com
- Keywords
- oncology, pharmaceutical, biotech, multiplemyeloma, lymphoma, solidtumors, clinicalresearch, clinicaltrials, research, drugdiscovery, medical, healthcare.
- HQ
- Newton, MA
Karyopharm Therapeutics Inc. Questions
Karyopharm Therapeutics Inc.'s website is http://www.karyopharm.com
Karyopharm Therapeutics Inc.'s LinkedIn profile is https://www.linkedin.com/company/karyopharm
Karyopharm Therapeutics Inc. has
346 employees.
View email and phone details for 346
employees at Karyopharm Therapeutics Inc..
Karyopharm Therapeutics Inc.'s industry is
Pharmaceutical Manufacturing
Karyopharm Therapeutics Inc.'s top competitors are
Genentech,
Vertex Pharmaceuticals,
Sarepta Therapeutics,
Deciphera Pharmaceuticals,
Blueprint Medicines,
Agios Pharmaceuticals,
Alnylam Pharmaceuticals,
Replimune,
Kite Pharma,
Acadia Pharmaceuticals Inc..
Karyopharm Therapeutics Inc.'s categories are Pharmaceutical Manufacturing
